Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 14722038

Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2004 Jan 15
First author
Loehrer PJ Sr

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2004 Jun 1;22(11):2261
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null

Authors and identifiers

  1. name
    Loehrer PJ Sr
    type
    Author
  2. name
    Wang W
    type
    Author
  3. name
    Johnson DH
    type
    Author
  4. name
    Aisner SC
    type
    Author
  5. name
    Ettinger DS
    type
    Author
  6. name
    Eastern Cooperative Oncology Group Phase II Trial
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Loehrer PJ Sr
    type
    Author
  2. name
    Wang W
    type
    Author
  3. name
    Johnson DH
    type
    Author
  4. name
    Aisner SC
    type
    Author
  5. name
    Ettinger DS
    type
    Author
  6. name
    Eastern Cooperative Oncology Group Phase II Trial
    type
    CollectiveName
bibliography ids
  1. nci-bib-0c1ce397f778d8f288cd98f5
book metadata
content sha256
9856910d2f17637c4483d106a7b7a3204c22eba26724a1abe4ddffdbb3b026e9
document type
citation
dois
  1. 10.1200/JCO.2004.02.047
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:14722038
immutable id
pubmed:14722038@9856910d2f17637c4483d106a7b7a3204c22eba26724a1abe4ddffdbb3b026e9
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
293-9
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2004 Jun 1;22(11):2261
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
outcomes validated
false
pmid
14722038
provenance
batch id
aee154f17d1b0501fe1f
provider
NCBI PubMed ESummary
record sha256
b6a6630f04b5b6a6bc6b025dd5b2e6c70d0e2d4d091c1766da6f1d0cbb21f0ed
response sha256
75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
retrieved at
2026-09-09T23:45:53.270896+00:00
publication date
display
2004 Jan 15
precision
day
year
2004
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/14722038/
title
Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.

Preserved source evidence · Not medical advice